Very Late Central Nervous System Relapse in a Patient with B Cell Lymphoblastic Lymphoma

Publisher： Karger

E-ISSN： 1421-9662|112|4|212-216

ISSN： 0001-5792

Source： Acta Haematologica, Vol.112, Iss.4, 2004-11, pp. : 212-216

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

B‐cell very late antigen‐4 deficiency reduces leukocyte recruitment and susceptibility to central nervous system autoimmunity

By  

ANNALS OF NEUROLOGY, Vol. 77, Iss. 5, 2015-05 ,pp. : 902-908

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hepatitis B Virus Reactivation in a Primary Central Nervous System Lymphoma Patient following Intrathecal Rituximab Treatment

By  

Acta Haematologica, Vol. 125, Iss. 3, 2010-12 ,pp. : 121-124

Karger

Access to resources Recommend Favorite

MYC protein expression is associated with poor prognosis in primary diffuse large B‐cell lymphoma of the central nervous system

By  

APMIS (ELECTRONIC), Vol. 123, Iss. 7, 2015-07 ,pp. : 596-603

John Wiley & Sons Inc

Access to resources Recommend Favorite

Very high levels of lactate dehydrogenase at diagnosis predict central nervous system relapse in acute promyelocytic leukaemia

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 4, 2015-05 ,pp. : 595-597

John Wiley & Sons Inc

Access to resources Recommend Favorite

Primary central nervous system diffuse large B‐cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart

By  

HISTOPATHOLOGY, Vol. 309-0167, Iss. 5, 2015-11 ,pp. : 625-635

John Wiley & Sons Inc

Access to resources Recommend Favorite